ESMO 2023 Insights: "Real-World Use Patterns, Effectiveness, & Tolerability of Sacituzumab Govitecan for 2L & Later Treatment of mTNBC"

1,025 views
November 7, 2023
0 Comments
Login to view comments. Click here to Login